epigallocatechin gallate has been researched along with Infarction, Middle Cerebral Artery in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, JB; Koh, PO; Park, DJ | 2 |
| Keyan, C; Nan, W; Tongtong, L; Wanshu, G; Zhonghang, X; Zhongxin, X | 1 |
| You, YP | 1 |
| Bai, Q; Dong, T; Lou, J; Lyu, Z; Pan, Z; Yang, X | 1 |
| Hong, JS; Kim, HY; Lee, JJ; Lee, KS; Lee, SR; Park, JW | 1 |
| Chung, ME; Hong, BY; Im, S; Kim, HS; Kim, HW; Kim, TM; Kim, YK; Ko, YJ; Lee, JI; Lim, SH | 1 |
| Chen, Y; Cheng, Z; Ding, J; Fu, G; Guo, LJ; He, W; Zhao, B; Zhao, Y | 1 |
| Ikeda, M; Suzuki, M; Tabuchi, M; Tomita, T; Umegaki, K | 1 |
| Choi, YB; Kim, BS; Kim, DJ; Kim, YI; Lee, KS | 1 |
| Appleton, I; Helps, SC; Nair, SM; Rahman, RM; Rosengren, RJ; Shaw, OM; Sims, NR | 1 |
11 other study(ies) available for epigallocatechin gallate and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats.
Topics: Animals; Apoptosis; Brain Ischemia; Caspase 3; Catechin; Cerebral Infarction; Disease Models, Animal; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Poly(ADP-ribose) Polymerases; Rats, Sprague-Dawley | 2020 |
Identification of regulated proteins by epigallocatechin gallate treatment in an ischemic cerebral cortex animal model: a proteomics approach.
Topics: Animals; Catechin; Cerebral Cortex; Disease Models, Animal; Infarction, Middle Cerebral Artery; Proteomics; Rats; Rats, Sprague-Dawley; Rodent Diseases | 2021 |
Epigallocatechin-3-Gallate Reduces Neuronal Apoptosis in Rats after Middle Cerebral Artery Occlusion Injury via PI3K/AKT/eNOS Signaling Pathway.
Topics: Animals; Apoptosis; Brain Ischemia; Catechin; Chromones; Infarction, Middle Cerebral Artery; Male; Morpholines; Neuroprotective Agents; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction | 2018 |
Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Catechin; Disease Models, Animal; Drug Therapy, Combination; Fibrinolytic Agents; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Neuroprotective Agents; Permeability; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Sensory Gating; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2016 |
Epigallocatechin-3-gallate promotes angiogenesis via up-regulation of Nfr2 signaling pathway in a mouse model of ischemic stroke.
Topics: Angiogenesis Inducing Agents; Animals; Brain; Catechin; Disease Models, Animal; Flavonoids; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Neovascularization, Physiologic; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Protein Kinase Inhibitors; Random Allocation; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia.
Topics: Animals; Catechin; Flavonoids; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Phenols; Polyphenols; Tea; Tetrazolium Salts; Up-Regulation | 2010 |
The functional effect of epigallocatechin gallate on ischemic stroke in rats.
Topics: Animals; Behavior, Animal; Brain Infarction; Catechin; Disease Models, Animal; Hindlimb; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sensory Gating; Statistics, Nonparametric | 2010 |
EGCG ameliorates the suppression of long-term potentiation induced by ischemia at the Schaffer collateral-CA1 synapse in the rat.
Topics: Amino Acids; Animals; Brain Infarction; Brain Ischemia; CA1 Region, Hippocampal; Catechin; Cell Shape; Cerebral Cortex; Extracellular Space; Glucose; Infarction, Middle Cerebral Artery; Long-Term Potentiation; Male; Neurons; Oxygen; Rats; Rats, Sprague-Dawley; Synapses | 2012 |
Protective effects of green tea catechins on cerebral ischemic damage.
Topics: Animals; Brain Ischemia; Catechin; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Infarction, Middle Cerebral Artery; Interleukin-3; Male; Malondialdehyde; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Plant Extracts; Rats; Rats, Wistar; Recombinant Fusion Proteins; Recombinant Proteins; Tea; Tyrosine | 2004 |
Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats.
Topics: Animals; Catechin; Hypoxia, Brain; Infarction, Middle Cerebral Artery; Lipid Peroxidation; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2004 |
(-)-Epigallocatechin gallate as an intervention for the acute treatment of cerebral ischemia.
Topics: Alanine Transaminase; Animals; Brain; Brain Ischemia; Catechin; Infarction, Middle Cerebral Artery; Liver; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2005 |